Cancer Res Treat.
2002 Aug;34(4):289-295.
The Outcome of Philadelphia Chromosome-Positive Adult ALL: Characteristics and Prognosis
- Affiliations
-
- 1Department of Internal Medicine, Hallym University College of Medicine, Chunchon, Korea.
- 2Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- 3Department of Clinical Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Abstract
-
The Philadelphia (Ph) chromosome is a well- known chromosome abnormality in adults with B-lineage ALL, and is associated with a poor prognosis. This study compared the clinical manifestations and prognosis in adult Ph-positive and Ph-negative ALL patients.
MATERIALS AND METHODS
We retrospectively analyzed the clinical records of adult patients newly diagnosed as B-lineage ALL, between January 1995 and February 2001. Fifty five patients were included in this study. We divided the patients into Ph-positive and Ph-negative groups.
RESULTS
Eighteen of the 55 patients (32.7%) were found to have the Ph chromosome. At initial diagnosis, the Ph-positive patients had higher circulating leukocyte counts, lower platelet counts and had a greater tendency to bleed, than the Ph-negative group. The complete remission rates were 83.3% and 83.8% for the Ph-positive and the Ph-negative groups, respectively. Four of the Ph-positive, and 13 of the Ph-negative, patients underwent allogenic bone marrow transplantation. The median follow-up for the surviving patients was 39.3 months. The three-year survival rates were 10.4% and 51.8% for the Ph-positive and the Ph-negative groups, respectively. The median disease-free survival was 7.7 months for the Ph-positive group, but did not reach the median value in the Ph-negative group. Among the Ph-positive patients, age was the only factor that had an impact on the disease outcome.
CONCLUSION
In adult B-lineage ALL, the Ph-positive patients had similar complete remission rates to other patients; however, the remission was of shorter duration, with a higher relapse rate in the Ph-positive patients. More effective treatments are needed to improve the survival of the Ph-positive patients.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Complete remission of philadelphia chromosome-positive acute myeloid leukemia with imatinib mesylate
- Two Cases of Chronic Myeloid Leukemia in Lymphoid Blast Phase Presented as Philadelphia-Positive Acute Lymphoblastic Leukemia
- A Case of Myelocytic Leukemia with Philadelphia Chromosome
- Outcome of Treatment in Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood
